BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31204440)

  • 1. Antitumor Potential of Fibulin-5 in Breast Cancer Cells Depends on Its RGD Cell Adhesion Motif.
    Mohamedi Y; Fontanil T; Cobo T; Vega JA; Cobo JL; Pérez-Basterrechea M; Cobo J; Obaya ÁJ; Cal S
    Cell Physiol Biochem; 2019; 53(1):87-100. PubMed ID: 31204440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS.
    Schluterman MK; Chapman SL; Korpanty G; Ozumi K; Fukai T; Yanagisawa H; Brekken RA
    Dis Model Mech; 2010; 3(5-6):333-42. PubMed ID: 20197418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells.
    Mohamedi Y; Fontanil T; Solares L; Garcia-Suárez O; García-Piqueras J; Vega JA; Cal S; Obaya AJ
    Int J Oncol; 2016 Apr; 48(4):1447-56. PubMed ID: 26891749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-binding and cell-adhesion studies of fibulins reveal a particular affinity for alpha IIb beta 3.
    Pfaff M; Sasaki T; Tangemann K; Chu ML; Timpl R
    Exp Cell Res; 1995 Jul; 219(1):87-92. PubMed ID: 7543056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells.
    Fontanil T; Rúa S; Llamazares M; Moncada-Pazos A; Quirós PM; García-Suárez O; Vega JA; Sasaki T; Mohamedi Y; Esteban MM; Obaya AJ; Cal S
    Oncotarget; 2014 Mar; 5(5):1253-64. PubMed ID: 24457941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
    Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
    Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers.
    Bartolomé RA; Torres S; Isern de Val S; Escudero-Paniagua B; Calviño E; Teixidó J; Casal JI
    Oncotarget; 2017 Jan; 8(1):215-227. PubMed ID: 27966446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of selective cell attachment by the RGD sequence in dentine matrix protein 1.
    Kulkarni GV; Chen B; Malone JP; Narayanan AS; George A
    Arch Oral Biol; 2000 Jun; 45(6):475-84. PubMed ID: 10775676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression.
    Yue W; Sun Q; Landreneau R; Wu C; Siegfried JM; Yu J; Zhang L
    Cancer Res; 2009 Aug; 69(15):6339-46. PubMed ID: 19584278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of extracellular matrix proteins fibulin-1 and fibulin-2 with fibronectin in bone marrow stroma.
    Gu YC; Nilsson K; Eng H; Ekblom M
    Br J Haematol; 2000 May; 109(2):305-13. PubMed ID: 10848816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual function of RGD-modified VEGI-192 for breast cancer treatment.
    Wu J; Jiang Y; Yang W; He Z; Meng S; Zhang Q; Lin M; Zhang H; Li W; Yang Y; Jia Y; Qian L; Lu D; Cai W; Luo G; Wang Y; Zhu X; Li M
    Bioconjug Chem; 2012 Apr; 23(4):796-804. PubMed ID: 22455451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers.
    Djokic J; Fagotto-Kaufmann C; Bartels R; Nelea V; Reinhardt DP
    J Biol Chem; 2013 Aug; 288(31):22821-35. PubMed ID: 23782690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
    Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
    World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW; Hota C; Shigeyama Y; D'Errico JA; Somerman MJ; Chambers AF
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An RGD motif present in cadherin 17 induces integrin activation and tumor growth.
    Bartolomé RA; Peláez-García A; Gomez I; Torres S; Fernandez-Aceñero MJ; Escudero-Paniagua B; Imbaud JI; Casal JI
    J Biol Chem; 2014 Dec; 289(50):34801-14. PubMed ID: 25336636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.
    Fontanil T; Álvarez-Teijeiro S; Villaronga MÁ; Mohamedi Y; Solares L; Moncada-Pazos A; Vega JA; García-Suárez O; Pérez-Basterrechea M; García-Pedrero JM; Obaya AJ; Cal S
    Oncotarget; 2017 Feb; 8(8):13716-13729. PubMed ID: 28099917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust Therapeutic Efficacy of Matrix Metalloproteinase-2-Cleavable Fas-1-RGD Peptide Complex in Chronic Inflammatory Arthritis.
    Nam EJ; Kang JH; Sa KH; Sung S; Park JY; Jo DG; Park JH; Kim IS; Kang YM
    PLoS One; 2016; 11(10):e0164102. PubMed ID: 27741237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth.
    Xie L; Palmsten K; MacDonald B; Kieran MW; Potenta S; Vong S; Kalluri R
    Exp Biol Med (Maywood); 2008 Feb; 233(2):155-62. PubMed ID: 18222970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
    Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
    Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.